These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4093039)

  • 1. [Blood transfusion in thalassemia--the Jerusalem experience].
    Goldfarb AW; Stupp-DaCosta Y; Manny N; Rachmilewitz EA
    Harefuah; 1985 Nov; 109(10):265-8. PubMed ID: 4093039
    [No Abstract]   [Full Text] [Related]  

  • 2. Priapism in a non-black with sickle cell anemia associated with alpha-thalassemia.
    Fich A; Rachmilewitz EA
    Am J Hematol; 1981; 10(3):313-5. PubMed ID: 7246538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurologic complications after blood transfusion in patients with chronic anemia].
    Menghi P; Bezzi TM
    Pediatria (Napoli); 1983; 91(2-3):121-9. PubMed ID: 6664724
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV infection and AIDS in thalassemia and sickle cell disease.
    Girot R; Lefrere JJ
    Haematologica; 1990; 75 Suppl 5():128-31. PubMed ID: 2086373
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood transfusion modalities in sickle cell anemia and thalassemia].
    Girot R
    Transfus Clin Biol; 1994; 1(1):19-21. PubMed ID: 8186848
    [No Abstract]   [Full Text] [Related]  

  • 6. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up.
    Ocak S; Kaya H; Cetin M; Gali E; Ozturk M
    Arch Med Res; 2006 Oct; 37(7):895-8. PubMed ID: 16971232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusion therapy in beta-thalassemia and sickle-cell anemia].
    Politis K
    Gematol Transfuziol; 1992 Jan; 37(1):6-12. PubMed ID: 1618384
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of thalassemia and sickle cell anemia in children].
    Girot R
    Ann Pediatr (Paris); 1978; 25(5-6):277-84. PubMed ID: 16114336
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.
    Gader AG; Al Ghumlas AK; Al-Momen AK
    Transfus Apher Sci; 2008 Dec; 39(3):199-204. PubMed ID: 18951063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal removal of iron with immobilized desferrioxamine.
    Ambrus CM; Anthone S; Deshpande G; Horvath C; Kalghatgi K
    ASAIO Trans; 1987; 33(3):749-53. PubMed ID: 3676013
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous chelation therapy with deferoxamine.
    Cohen A; Mizanin J; Schwartz E
    Prog Clin Biol Res; 1989; 309():125-31. PubMed ID: 2780746
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nursing contribution to research issues in blood transfusion.
    Ballard S
    Prof Nurse; 2003 Feb; 18(6):308-9. PubMed ID: 12630239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of hepatitis B, delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease.
    el-Hazmi MA; Ramia S
    J Trop Med Hyg; 1989 Feb; 92(1):1-5. PubMed ID: 2918572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study.
    Koshy M; Burd L; Wallace D; Moawad A; Baron J
    N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Thalassemia center of Antalya State Hospital: 15 years of experience (1994 to 2008).
    Canatan D
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):24-7. PubMed ID: 23128337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of sickle cell disease].
    Aluoch JR
    Ned Tijdschr Geneeskd; 1984 Jun; 128(25):1187-90. PubMed ID: 6462265
    [No Abstract]   [Full Text] [Related]  

  • 20. [The post-transfusional toxoplasmosis (author's transl)].
    Valbonesi M; Garelli S; Vazzana A; Picerno G
    Quad Sclavo Diagn; 1979 Jun; 15(2):243-7. PubMed ID: 554162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.